Ligand Pharmaceuticals Incorporated Insider Transactions
Ligand Pharmaceuticals Incorporated Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
KOZARICH JOHN W
Director |
Sell | 267 @ $161.51 | $43.12 K | 45,722 | 09/02/2025 | 09/04/2025 | |
|
KOZARICH JOHN W
Director |
Sell | 115 @ $162.52 | $18.69 K | 45,607 | 09/02/2025 | 09/04/2025 | |
|
KOZARICH JOHN W
Director |
Sell | 85 @ $164.25 | $13.96 K | 45,522 | 09/02/2025 | 09/04/2025 | |
|
KOZARICH JOHN W
Director |
Sell | 467 @ $131.88 | $61.59 K | 45,989 | 08/01/2025 | 08/05/2025 | |
|
KOZARICH JOHN W
Director |
Sell | 934 @ $125.00 | $116.75 K | 46,456 | 07/10/2025 | 07/11/2025 | |
|
Reardon Andrew
CLO & Secretary |
Sell | 500 @ $114.08 | $57.04 K | 31,903 | 06/23/2025 | 06/24/2025 | |
|
Reardon Andrew
CLO & Secretary |
Sell | 500 @ $114.54 | $57.27 K | 32,403 | 06/10/2025 | 06/12/2025 | |
|
Reardon Andrew
CLO & Secretary |
Sell | 1,000 @ $104.00 | $104.00 K | 32,903 | 05/15/2025 | 06/02/2025 | |
|
Davis Todd C
CEO |
Buy | 5,523 @ $105.67 | $583.63 K | 161,234 | 05/09/2025 | 05/13/2025 | |
|
Davis Todd C
CEO |
Buy | 2,307 @ $104.53 | $241.15 K | 155,711 | 05/09/2025 | 05/13/2025 | |
|
Davis Todd C
CEO |
Buy | 1,680 @ $104.57 | $175.68 K | 153,404 | 05/09/2025 | 05/13/2025 | |
|
Espinoza Octavio
CFO |
Buy | 500 @ $104.40 | $52.20 K | 27,932 | 05/09/2025 | 05/13/2025 | |
|
Espinoza Octavio
CFO |
Buy | 1,000 @ $103.89 | $103.89 K | 27,432 | 05/09/2025 | 05/13/2025 | |
|
Espinoza Octavio
CFO |
Sell | 5,000 @ $115.03 | $575.15 K | 18,879 | 03/04/2025 | 03/06/2025 | |
|
Espinoza Octavio
CFO |
Sell | 2,104 @ $116.37 | $244.85 K | 20,647 | 12/23/2024 | 12/26/2024 | |
|
LAMATTINA JOHN L
Director |
Sell | 2,406 @ $123.65 | $297.50 K | 29,515 | 11/27/2024 | 12/02/2024 | |
|
Korenberg Matthew E
President & COO |
Sell | 7,090 @ $101.61 | $720.38 K | 50,978 | 09/23/2024 | 09/24/2024 | |
|
Reardon Andrew
CLO & Secretary |
Sell | 2,000 @ $99.60 | $199.20 K | 22,534 | 09/23/2024 | 09/25/2024 | |
|
Korenberg Matthew E
President & COO |
Sell | 2,481 @ $100.05 | $248.23 K | 58,068 | 09/23/2024 | 09/24/2024 | |
|
Korenberg Matthew E
President & COO |
Sell | 201 @ $102.05 | $20.51 K | 50,777 | 09/23/2024 | 09/24/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ligand Pharmaceuticals Incorporated FAQ's
The list of insiders at Ligand Pharmaceuticals Incorporated includes Espinoza Octavio, Davis Todd C, Reardon Andrew, KOZARICH JOHN W, Aryeh Jason, Gray Nancy Ryan, LAMATTINA JOHN L.
Insiders have sold a total of 29.13 K Ligand Pharmaceuticals Incorporated shares in the last 12 months for a total of 4.62 M sold.
The following insiders have sold Ligand Pharmaceuticals Incorporated shares in the last 12 months: Espinoza Octavio ($1.16 M), Reardon Andrew ($218.31 K), KOZARICH JOHN W ($500.40 K), Aryeh Jason ($1.71 M), Gray Nancy Ryan ($619.43 K), LAMATTINA JOHN L ($417.89 K),
Insiders have purchased a total of 11.01 K Ligand Pharmaceuticals Incorporated shares in the last 12 months for a total of 1.16 M.
The following insiders have purchased Ligand Pharmaceuticals Incorporated shares in the last 12 months: Davis Todd C ($1.00 M), Espinoza Octavio ($156.09 K),